- Report
- February 2026
- 506 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 363 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- November 2025
- 200 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- November 2025
- 200 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more